Koios Medical Press Releases

• Published on December 2, 2024 - 07:08 GMT

  

  Koios Medical Announces FDA Clearance of Next Generation Koios DS Version 3.6 SmartUltrasoundTM Software

  Next generation "AI Engine" combines diagnostic precision with workflow optimization now cleared for use in the US and beyond. NEW YORK, NY, UNITED STATES, December 2, 2024 /⁨EINPresswire.com⁩/ -- Koios Medical, Inc, a leading innovator in …

  Distribution channels: Healthcare & Pharmaceuticals Industry, IT Industry ...
• Published on February 28, 2023 - 14:00 GMT

  

  Mitsui & Co. invests in U.S. based healthcare technology company Koios Medical

  Partnership expands access to AI enabled software for early cancer detection and diagnosis, elevating quality & advancing wellness worldwide. NEW YORK CITY, NY, UNITED STATES, February 28, 2023 /⁨EINPresswire.com⁩/ -- Mitsui & Co., Ltd. (" …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on February 21, 2023 - 09:59 GMT

  

  Koios Medical Announces Distribution Partnership with RMS Medical Devices for Benelux Region

  Expanding access to innovative and proven radiology Ai solutions for early cancer detection and improved patient outcomes. NEW YORK, UNITED STATES, February 21, 2023 /⁨EINPresswire.com⁩/ -- Koios Medical, Inc., a leading medical imaging and artificial …

  Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ...
• Published on December 5, 2022 - 08:00 GMT

  

  Koios Medical Announces CE Marking for Smart Ultrasound® Software for Thyroid and Breast Cancer Diagnosis

  Radiology AI software for early cancer diagnosis uses computer vision to automate interpretation and reporting now available across EU and UK. NEW YORK, NY, UNITED STATES, December 5, 2022 /⁨EINPresswire.com⁩/ -- Koios Medical, a leader in cancer …

  Distribution channels: Business & Economy, Culture, Society & Lifestyle ...
• Published on December 20, 2021 - 13:00 GMT

  

  FDA Clears Koios Medical Smart Ultrasound® AI Software for Thyroid and Breast Cancer Diagnosis.

  AI enabled software cleared for use by physicians interpreting ultrasound exams. Improves cancer detection with fewer false positives and avoidable procedures. NEW YORK CITY, NEW YORK, UNITED STATES OF AMERICA, December 20, 2021 /⁨EINPresswire.com⁩/ -- …

  Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
• Published on December 17, 2021 - 19:44 GMT

  

  FDA Clears Koios Medical Smart Ultrasound® AI Software for Thyroid and Breast Cancer Diagnosis.

  AI enabled software cleared for use by physicians interpreting ultrasound exams. Improves cancer detection with fewer false positives and avoidable procedures. NEW YORK, NEW YORK, USA, December 17, 2021 /⁨EINPresswire.com⁩/ -- Koios Medical, a fast- …

  Distribution channels: Beauty & Hair Care, Consumer Goods ...
• Published on November 15, 2021 - 13:00 GMT

  

  Koios Medical Receives Health Canada Approval for Smart Ultrasound® AI Software for Breast Cancer Detection.

  Smart Ultrasound software available in the US, across Europe, UK, the Middle East and South America is now available in Canada for improved diagnostic accuracy. NEW YORK, USA, November 15, 2021 /⁨EINPresswire.com⁩/ -- Koios Medical, a fast-growing …

  Distribution channels: Beauty & Hair Care, Healthcare & Pharmaceuticals Industry ...
• Published on September 16, 2021 - 23:51 GMT

  Koios DS Breast™ AI Available on GE Healthcare’s Automated Breast Ultrasound to Support Early Breast Cancer Detection

  Koios Medical and GE Healthcare join forces again in early breast cancer detection making Koios DS Breast AI software available on the Invenia 2.0 ABUS system. GE Healthcare (NYSE:GE) NEW YORK, NEW YORK, USA, September 16, 2021 /⁨EINPresswire.com⁩/ -- …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on April 11, 2021 - 17:32 GMT

  

  Koios Medical Announces FDA Breakthrough Device Designation for Early Cancer Detection AI Software.

  Koios Medical announced receiving Breakthrough Device designation from the USFDA for AI software to detect and diagnosis breast and thyroid cancer. NEW YORK, NY, UNITED STATES, April 11, 2021 /⁨EINPresswire.com⁩/ -- Koios Medical, a US developer of …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on March 16, 2021 - 18:59 GMT

  

  Koios Medical Announces CE Mark Approval and European Market Launch for Breast Cancer Detection AI Software.

  Koios Medical, a fast-growing developer of AI-based software received CE Mark approval for its system to accurately diagnose breast cancer via ultrasound. NEW YORK, NY, USA, March 16, 2021 /⁨EINPresswire.com⁩/ -- Koios Medical, Inc., a fast-growing …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...